LCTX
Lineage Cell Therapeutics, Inc.
$1.07
$266.75M
Price
$1.07
Market Cap
$266.75M
Revenue CAGR (5Y)
+19.1%
EPS CAGR (5Y)
-12.8%
Revenue Growth
Year over Year-11.1%
2016
-20.4%
2017
-21.0%
2018
+4.4%
2019
-47.7%
2020
+404.0%
2021
+277.4%
2022
-39.2%
2023
+6.2%
2024
+53.2%
2025
EPS Growth
Year over Year+159.3%
2016
-148.6%
2017
-111.8%
2018
+77.4%
2019
-72.2%
2020
-85.7%
2021
+42.3%
2022
+20.0%
2023
+22.5%
2024
-201.1%
2025